Home Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

FPG #8: Alternative Treatments in Psychiatry
FPG #7: Critical Care in Neurology
Free Medical Books

  Bladder Cancer

  Free Subscription


26.12.2011

1 Biochem Biophys Res Commun
2 BJU Int
1 DNA Cell Biol
1 Eur Urol
1 Expert Opin Investig Drugs
1 Int J Oncol
1 J Clin Oncol
1 J Histochem Cytochem
7 J Urol
2 Mol Biol Rep
1 Mol Med Report
1 Nat Rev Urol
1 Pathol Oncol Res
1 Srp Arh Celok Lek
1 Ultrasound Obstet Gynecol
1 Urol Clin North Am
1 Urol Oncol
3 Urologe A


   Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Biochem Biophys Res Commun

  1. YOSHINO H , Enokida H, Chiyomaru T, Tatarano S, et al
    Tumor suppressive microRNA-1 mediated novel apoptosis pathways through direct inhibition of splicing factor arginine/serine-rich 9 (SRSF9/SRp30c) in bladder cancer.
    Biochem Biophys Res Commun. 2011.
    PubMed     Text format     Related articles    Abstract available



    BJU Int

  2. CANDA AE , Atmaca AF, Altinova S, Akbulut Z, et al
    Robot-assisted nerve-sparing radical cystectomy with bilateral extended pelvic lymph node dissection (PLND) and intracorporeal urinary diversion for bladder cancer: initial experience in 27 cases.
    BJU Int. 2011 Dec 16. doi: 10.1111/j.1464-410X.2011.10794.
    PubMed     Text format     Related articles    Abstract available


  3. FEYISETAN O , Tracey C, Hellawell GO
    Probiotics, dendritic cells and bladder cancer.
    BJU Int. 2011 Dec 16. doi: 10.1111/j.1464-410X.2011.10749.
    PubMed     Text format     Related articles    Abstract available



    DNA Cell Biol

  4. FREDERICKS WJ , McGarvey T, Wang H, Lal P, et al
    The bladder tumor suppressor protein TERE1 (UBIAD1) modulates cell cholesterol: implications for tumor progression.
    DNA Cell Biol. 2011;30:851-64.
    PubMed     Text format     Related articles    Abstract available



    Eur Urol

  5. ROSENBLATT R , Sherif A, Rintala E, Wahlqvist R, et al
    Pathologic Downstaging Is a Surrogate Marker for Efficacy and Increased Survival Following Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-Invasive Urothelial Bladder Cancer.
    Eur Urol. 2011.
    PubMed     Text format     Related articles    Abstract available



    Expert Opin Investig Drugs

  6. YUTKIN V , Chin J
    Apaziquone as an intravesical therapeutic agent for urothelial non-muscle-invasive bladder cancer.
    Expert Opin Investig Drugs. 2011.
    PubMed     Text format     Related articles    Abstract available



    Int J Oncol

  7. TATARANO S , Chiyomaru T, Kawakami K, Enokida H, et al
    Novel oncogenic function of mesoderm development candidate 1 and its regulation by MiR-574-3p in bladder cancer cell lines.
    Int J Oncol. 2011 Dec 13. doi: 10.3892/ijo.2011.1294.
    PubMed     Text format     Related articles    Abstract available



    J Clin Oncol

  8. DIZDAR O , Demirci U
    p53 Status in Locally Advanced Bladder Cancer.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   



    J Histochem Cytochem

  9. TORZSOK P , Riesz P, Kenessey I, Szekely E, et al
    Claudins and ki-67: potential markers to differentiate low- and high-grade transitional cell carcinomas of the urinary bladder.
    J Histochem Cytochem. 2011;59:1022-30.
    PubMed     Text format     Related articles    Abstract available



    J Urol

  10. SALINAS-SANCHEZ AS , Donate-Moreno MJ, Lopez-Garrido MP, Gimenez-Bachs JM, et al
    Role of CYP1B1 Gene Polymorphisms in Bladder Cancer Susceptibility.
    J Urol. 2011.
    PubMed     Text format     Related articles    Abstract available


  11. ESWARA JR , Efstathiou JA, Heney NM, Paly J, et al
    Complications and Long-Term Results of Salvage Cystectomy After Failed Bladder Sparing Therapy for Muscle Invasive Bladder Cancer.
    J Urol. 2011.
    PubMed     Text format     Related articles    Abstract available


  12. HERR HW
    Intravesical Bacillus Calmette-Guerin Outcomes in Patients With Bladder Cancer and Asymptomatic Bacteriuria.
    J Urol. 2011.
    PubMed     Text format     Related articles    Abstract available


  13. REIS LO , Ferreira U, Billis A, Cagnon VH, et al
    Anti-Angiogenic Effects of the Superantigen Staphylococcal Enterotoxin B and Bacillus Calmette-Guerin Immunotherapy for Nonmuscle Invasive Bladder Cancer.
    J Urol. 2011.
    PubMed     Text format     Related articles    Abstract available


  14. MEIJER RP , Nunnink CJ, Wassenaar AE, Bex A, et al
    Standard Lymph Node Dissection for Bladder Cancer: Significant Variability in the Number of Reported Lymph Nodes.
    J Urol. 2011.
    PubMed     Text format     Related articles    Abstract available


  15. SHARIAT SF , Chromecki TF, Cha EK, Karakiewicz PI, et al
    Risk Stratification of Organ Confined Bladder Cancer After Radical Cystectomy Using Cell Cycle Related Biomarkers.
    J Urol. 2011.
    PubMed     Text format     Related articles    Abstract available


  16. KILTIE AE
    Using Gene Polymorphisms to Assess Bladder Cancer Risk: Progress and Challenges.
    J Urol. 2011.
    PubMed     Text format     Related articles   



    Mol Biol Rep

  17. JAISWAL PK , Goel A, Mandhani A, Mittal RD, et al
    Functional polymorphisms in promoter survivin gene and its association with susceptibility to bladder cancer in North Indian cohort.
    Mol Biol Rep. 2011.
    PubMed     Text format     Related articles    Abstract available


  18. SUN XF , Sun ZY, Pan B, Li L, et al
    Alteration in methylation pattern of oncogene Akt1 promoter region in bladder cancer.
    Mol Biol Rep. 2011.
    PubMed     Text format     Related articles    Abstract available



    Mol Med Report

  19. WU D , Tao J, Xu B, Li P, et al
    Downregulation of Dicer, a component of the microRNA machinery, in bladder cancer.
    Mol Med Report. 2011 Dec 14. doi: 10.3892/mmr.2011.
    PubMed     Text format     Related articles    Abstract available



    Nat Rev Urol

  20. FLAIG TW , Theodorescu D
    Bladder cancer in 2011: The dawn of personalized medicine.
    Nat Rev Urol. 2011 Dec 20. doi: 10.1038/nrurol.2011.
    PubMed     Text format     Related articles   



    Pathol Oncol Res

  21. FERNANDEZ-ACENERO MJ , Cordova S, Manzarbeitia F, Medina C, et al
    Immunohistochemical profile of urothelial and small cell carcinomas of the bladder.
    Pathol Oncol Res. 2011;17:519-23.
    PubMed     Text format     Related articles    Abstract available



    Srp Arh Celok Lek

  22. DAMJANOV I , Golubovic M
    Histopathology of urinary bladder carcinoma: less common variants.
    Srp Arh Celok Lek. 2011;139.
    PubMed     Text format     Related articles    Abstract available



    Ultrasound Obstet Gynecol

  23. LAMBRECHTS S , Van Calsteren K, Capoen A, Op de Beeck K, et al
    A case of polypoid endometriosis of the bladder during pregnancy mimicking urachal carcinoma.
    Ultrasound Obstet Gynecol. 2011 Mar 3. doi: 10.1002/uog.8985.
    PubMed     Text format     Related articles    Abstract available



    Urol Clin North Am

  24. HAKIMI AA , Ghavamian R
    Feasibility of minimally invasive lymphadenectomy in bladder and prostate cancer surgery.
    Urol Clin North Am. 2011;38:407-18.
    PubMed     Text format     Related articles    Abstract available



    Urol Oncol

  25. LIN HY , Yang MC, Huang CH, Wu WJ, et al
    Polymorphisms of TP53 are markers of bladder cancer vulnerability and prognosis.
    Urol Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available



    Urologe A

  26. REXER H
    [First line therapy for local advanced or metastatic urothelial cell carcinoma: randomized phase II study to investigate the combination of vinflunine with gemcitabine and vinflunine with carboplatin in patients unfit for cisplatin therapy with advanc
    Urologe A. 2011;50:974-6.
    PubMed     Text format     Related articles   


  27. MULLER SC , Strunk T
    [Is the training and continuing education for urologists in Germany still up to date?].
    Urologe A. 2011;50:946-51.
    PubMed     Text format     Related articles    Abstract available


  28. MAY M , Fritsche HM, Gilfrich C, Brookman-May S, et al
    [Influence of older age on survival after radical cystectomy due to urothelial carcinoma of the bladder: survival analysis of a German multi-centre study after curative treatment of urothelial carcinoma of the bladder].
    Urologe A. 2011;50:821-9.
    PubMed     Text format     Related articles    Abstract available



Thank you for your interest in scientific medicine.


Amedeo is a Flying Publisher website.

   Design: